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Edited by Ned ManteiAbstract Methyl CpG binding protein 2 (MeCP2) is a basic
protein that contains a DNA methyl binding domain. The mech-
anism by which the highly positive charge of MeCP2 and its abil-
ity to bind methylated DNA contribute to the speciﬁcity of its
binding to chromatin has long remained elusive. In this paper,
we show that MeCP2 binds to nucleosomes in a very similar
way to linker histones both in vitro and in vivo. However, its
binding speciﬁcity strongly depends on DNA methylation. We
also observed that as with linker histones, this binding is indepen-
dent of the core histone H3 N-terminal tail and is not aﬀected by
histone acetylation.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Methyl CpG binding protein 2 (MeCP2) is a member of the
methyl binding domain (MBD) [1] family of proteins that was
ﬁrst identiﬁed in 1989 [2]. Mutations of this protein have been
shown to be largely responsible for Rett syndrome [3,4], a neu-
rodevelopmental disorder that primarily aﬀects young girls [5].
MeCP2 binds 5 0 methylated CpG DNA regions within a chro-
matin context and can mediate changes to the local chromatin
structure through the recruitment of additional trans-acting
factors [6]. Chromatin is a macromolecular complex composed
of histone proteins associated with DNA. The DNA wraps
around a core histone octamer [2 (H2A–H2B) dimers + (H3–
H4)2 tetramer] in approximately two left-handed turns to form
a nucleosome. The nucleosome is the basic repeating unit of
chromatin structure. Adjacent nucleosomes are connected by
the intervening linker DNA. Higher order chromatin struc-
tures are achieved in part by the binding of linker histones
to the linker DNA which facilitates compaction of the chroma-
tin ﬁbre [7].
Understanding the constraints imposed by chromatin on the
binding of MeCP2 to its targeted methylated DNA sites has
proven to be complicated. About 10 years ago, Nan et al. pub-
lished an interesting paper [8] which characterized the interac-
tion of MeCP2 with chromatinized methylated/unmethylated*Corresponding author. Fax: +1 250 721 8855.
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histones. The results of such work conclusively showed that
MeCP2 preferentially binds nucleosome-organized methylated
DNA and that MeCP2 was able to displace 40% of histone H1.
It was not clear if MeCP2 had any preference for the linker
DNA or for the nucleosome organized methylated DNA and
also where histone H1 was displaced from. Ensuing research
showed that MeCP2s interaction with mononucleosomes was
very similar to that of histone H1 and that hinted at a depen-
dence on DNAmethylation [9]. More recent in vitro work using
reconstituted oligo-nucleosome templates for MeCP2 binding
under very low ionic strength conditions showed that MeCP2
could produce novel levels of chromatin compaction in the ab-
sence of DNA methylation [10]. This has led to the notion that
MeCP2 might also act as a global suppressor of gene activity
[10,11]. Nevertheless, when the in vitro reconstitutions using
unmethylated DNA templates [10] were repeated using methyl-
ated DNA constructs, a chromatosome-like structure was ob-
served upon MeCP2 binding [12] in agreement with earlier
published results [9]. Despite all this biochemical in vitro eﬀort,
very little is known about the interactions of MeCP2 with chro-
matin in an in vivo setting.2. Materials and methods
2.1. DNA construct
The (5S-pmbs) DNA templates used in this work were derived from
a 207-12 construct of the sea urchin 5S rRNA gene [13]. Upon excision
of a 207 bp fragment by digestion with RsaI, the 5S-207 fragment was
cloned and PCR-modiﬁed to create the preferential methylation bind-
ing sites (pmbs) shown in Fig. 1. Pmbs for MeCP2 were created follow-
ing the consensus sequence criterion deﬁned in [14]. 5S-pmbs0 refers to
the construct which contains no pmbs outside of the core histone bind-
ing region. The DNA templates were radiolabeled with [c-32P]ATP
using T4 polynucleotide kinase [15]. DNA was incubated with CpG
Methyltransferase (M.SssI) (New England Biolabs) for 4 h at 37 C
and the extent of methylation was checked by digestion with HpaII.
2.2. Chromatin preparation
Chromatin from HeLa S3 cells grown in suspension in the presence
or absence of 5 mM sodium butyrate was digested with micrococcal
nuclease (Worthington) (30 U/mg) in the presence of 50 mM NaCl,
5 mM MgCl2, 1 mM CaCl2, 10 mM PIPES (pH 6.8) buﬀer for
15 min at 37 C and centrifuged immediately to produce a supernatant
(fraction SI). The nuclear pellet was subsequently lysed in 0.25 mM
EDTA to further generate a supernatant (fraction SE) and a lysis-resis-
tant pellet (fraction P) as described in [16]. The SI supernatant was
fractionated by 5–20% sucrose gradients using a Beckman L8-70M
ultracentrifuge [16]. MeCP2 amounts were further characterized by
Western blotting and native-PAGE analysis.ation of European Biochemical Societies.
Fig. 1. DNA templates. (A) Nucleotide sequence of the 5S-207
fragment [13]. The dashed black line indicates the main position
occupied by the histone octamer when this DNA is reconstituted into
nucleosomes [17]. The light- and dark-grey ellipsoids respectively
highlight the CpG sites without or with MeCP2 preferential binding
[14]. (B) Nucleotide sequence of the 5S-pmbs0 DNA used to generate
the diﬀerent pmbs constructs. The light-grey lines highlight the
adjacent CpG [A/T]P 4 consensus regions responsible for the high-
aﬃnity binding of MeCP2 [14]. The asterisks and numbers above them
point to the position of the newly introduced CpG pmbs using the 5S-
207 sequence as a reference for the nucleotide numbering.
Fig. 2. MeCP2 preferentially binds to methylated DNA in the presence
of competitor DNA. (A and B) Gel shift assays of the unmodiﬁed
207 bp 5S rRNA sequence (5S-207) non-methylated (Me) or SssI
methylated (+Me) in the absence (A) or in the presence (B) of poly(dI-
dC):poly(dI-dC) competitor. DNA samples were incubated with 0
(lanes 1 and 7), 0.3 (lanes 2 and 8), 0.6 (lanes 3 and 9), 1.2 (lanes 4 and
10), 2.4 (lanes 5 and 11) and 4.8 (lanes 6 and 12) pmol of MeCP2. C
and C1, C2, C3, C4: MeCP2–DNA complexes arising from binding of
MeCP2 to several of the MeCP2 CpG preferential binding sites which
are present in the 5S-207 DNA sequence; D: free DNA.
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2.3.1. DNA. DNA gel shift assays were done by incubating
0.15 pmol of 207 bp DNA and increasing amounts of MeCP2 (see
Fig. S1A) for 20 min at 25 C in a reaction mixture of 10 mM Tris-
HCl (pH7.5), 150 lg/ml BSA, 0.1% NP-40, 3 mM DTT, 5% glycerol
and 150 mM NaCl and 150 ng of poly(dI-dC):poly(dI-dC).
2.3.2. Nucleosomes. Gel shift assays with nucleosomes were per-
formed by incubating diﬀerent amounts (see ﬁgure legends) of reconsti-
tuted mononucleosomes and increasing amounts of MeCP2 for 20 min
at 25 C in the same reaction mixture as above (80 mM NaCl was used
in Fig. 5).3. Results and discussion
3.1. MeCP2 preferentially binds methylated linker DNA in the
proximity of the nucleosome
The template DNA used for the nucleosome reconstitutions
was a 207 bp DNA segment of the sea urchin 5S rRNA gene
(5S-207). This commonly used fragment is a positioning
sequence in which the histone octamer predominantly occupies
a well-deﬁned position (Fig. 1A) [17–19]. Prior to characteriz-
ing MeCP2 binding to reconstituted nucleosomes (Fig. S1D),
the binding preference of MeCP2 to both the methylated and
unmethylated naked (5S-207) DNA template was assessed
(Fig. 2). When incubated with MeCP2 in the absence of com-
petitor DNA, complexes of progressively lower electrophoretic
mobility were observed with increasing amounts of MeCP2,
both with methylated and unmethylated DNA (Fig. 2A). In
the presence of competitor DNA, MeCP2 binding to unmethy-
lated DNA was strongly suppressed, and a series of well-de-
ﬁned complexes was seen with methylated DNA (C1–C4;
Fig. 2B). These results conclusively show that in the absence
of competitor DNA (Fig. 2A), the MeCP2 binding preference
for methylated DNA (Fig. 2B) is completely abolished and
MeCP2 binds to both methylated and unmethylated DNA.This simple experiment brings up an important cautionary
note for the interpretation of those studies using (5S rRNA-re-
lated) unmethylated DNA templates [10] and underscores the
importance of using competitor DNA. The presence of com-
petitor DNA more likely reﬂects the chromatin environment
encountered by MeCP2 in the nucleus. The rather non-speciﬁc
binding of MeCP2 to methylated or unmethylated DNA in the
absence of competitor DNA (Fig. 2A) is merely a reﬂection of
the electrostatically driven interaction between the very basic
MeCP2 (pI = 10.0) and DNA. Importantly, DNA in the nucle-
osome retains many free phosphates as only a very limited
number of backbone phosphates interact with the core his-
tones [20–22]. Therefore, all the subsequent nucleosome exper-
iments described in this work were done using (radiolabeled)
DNA sequence-deﬁned nucleosomes simultaneously reconsti-
tuted with a 10-fold excess of background (cold) 146 bp ran-
dom sequence nucleosomes [23].
Fig. 3B–D shows that MeCP2 prefers binding to methylated
target domains [14] that occur in the linker domain outside of
the DNA region protected by the histone octamer. Similarly to
naked DNA (Fig. 2B), although less pronounced, it took
greater amounts of MeCP2 to shift unmethylated nucleosomes
than its methylated counterpart (compare lane 7 with lanes 13,
14 in Fig. 3B and lanes 5, 6 with lanes 9–12 in Fig. 3C). Fur-
thermore, the shift took place at lower MeCP2 concentrations
when the pmbs was located within the nucleosomal DNA out-
side of the preferential histone octamer position (compare
Fig. 3. MeCP2 preferentially binds to the methylated linker DNA
region closest to the nucleosome. (A) A cartoon representation of the
major position occupied by the histone octamer in the 5S rRNA gene
sequence [18,19,36]. (B) Gel shift assay of nucleosomes reconstituted
onto unmethylated (Me) or SssI-methylated (+Me) 5S-pmbs0.
Nucleosomes (0.9 pmol) were incubated with: 0 (lanes 1 and 8),
0.375 (lanes 2 and 9), 0.75 (lanes 3 and 10), 1.5 (lanes 4 and 11), 3.0
(lanes 5 and 12), 6.0 (lanes 6 and 13) and 12 (lanes 7 and 14) pmol of
MeCP2. (C) Same as in (B), but using nucleosomes reconstituted onto
5S-pmbs23. Samples were incubated with 0 (lanes 1 and 7), 0.75 (lanes
2 and 8), 1.5 (lanes 3 and 9), 3.0 (lanes 4 and 10), 6.0 (lanes 5 and 11)
and 12 (lanes 6 and 12) pmol of MeCP2. (D) Gel shift assay of
nucleosomes (0.9 pmol) reconstituted onto methylated 5S-pmbs 3,
10, 23 and 37 (see Fig. S1D). Samples were incubated with: 0
(lanes 1, 5, 9 and 13), 0.75 (lanes 2, 6, 10 and 14), 1.5 (lanes 3, 7, 11 and
15) and 3.0 (lanes 4, 8, 12 and 16) pmol of MeCP2. C1 and C2:
MeCP2–DNA complexes; D: free DNA; N: nucleosome. The C2
complexes appear only upon saturation of the linker preferential
binding site at very high ratios of MeCP2:nucleosome with likely
additional binding to less preferred sites within the nucleosome region.
Fig. 4. Neither removal of the H3 N-terminal tail nor histone
acetylation aﬀects the binding of MeCP2 to the nucleosome. (A and
B) Gel shifts of nucleosomes reconstituted onto methylated 5S-pmbs37
(A) using histone octamers with trypsinized H3 (37-H3DN) [see
Fig. S1B, lane T] or (B) using acetylated histone octamers (37Ac) (see
Fig. S1B and C, lanes N and T). Nucleosomes (2 pmol in A and
1.3 pmol in B) were incubated with 0 (lanes 1 and 5), 0.75 (lanes 2 and
6), 1.5 (lanes 3 and 7) or 3.0 (lanes 4 and 8) pmol MeCP2. C, D, N:
same as in Fig. 3.
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has a preference for the site where the linker DNA enters and
exits the nucleosome, a preferential methylation binding site
(pmbs) was moved to diﬀerent positions along the linker
DNA (Fig. 1B and Fig. 3A). Fig. 3D shows that the proximal
site (pmbs37) (six nucleotides away from the octamer) is
clearly a preferred binding site, similar to what is observed
for linker histones in the chromatosome [24,25]. Like linkerhistones, MeCP2 exhibits a preferential binding for cruciform
DNA structures that mimic the organization of DNA at the
entry and exit sites of the nucleosome in the chromatosome
structure [26].
To ensure that the binding aﬃnity of MeCP2 for the diﬀer-
ent pmbs observed in Fig. 3D was not aﬀected by the diﬀer-
ences in the sequence of the artiﬁcially created pmbs sites
shown in Fig. 1B, a control experiment was performed. The
higher aﬃnity exhibited by pmbs37 is unlikely due to this, as
it has the longest nucleotide span between the CpG and the
adjacent [A/T]P 4 [14]. Nevertheless, we repeated this experi-
ment using DNA constructs in which all the other pmbs have
an identical sequence to that of the pmbs37 (see Fig. S2A–C).
The results are shown in Fig. S2C and clearly show that the
diﬀerence in MeCP2 binding aﬃnity to nucleosomes depends
on the position of the pmbs rather than its particular sequence.
3.2. Binding of MeCP2 to chromatin does not depend on the
presence of the N-terminal tail of H3 and it is not aﬀected
by the presence of histone H1 or core histone acetylation
A recent study has provided evidence that in the chromato-
some-like structure resulting from the interaction of the nucle-
osome core particle with MeCP2, MeCP2 is in close proximity
to histone H3. It was suggested that a potential interaction be-
tween these two proteins may involve the N-terminal tail of
histone H3 [12]. The results of Fig. 4A show that the binding
of MeCP2 to the nucleosome is slightly favoured by the lack
of the N-terminal tail of histone H3 (compare shifts observed
in lanes 3 and 4 with those of lanes 7 and 8). This indicates that
while MeCP2 may interact in a region of the linker DNA that
partially overlaps with that occupied by the N-terminal tail of
H3 in the chromatosome, the presence or absence of the H3 N-
terminal tail is not a major determinant of MeCP2 binding.
This result is not surprising as the binding of linker histones
to nucleosomes does not depend upon the amino termini of
core histones [27]. It has been shown that the N-terminal tail
of histone H3 and linker histones have structural redundancy
in determining chromatin conformational stability. It is possi-
ble that MeCP2 exhibits a similar redundancy.
Similarly, acetylation of core histones does not appear to
strongly inﬂuence linker histone binding to the nucleosome
[28]. Hence, it would not be expected to have any major eﬀect
Fig. 5. MeCP2 binds to nucleosomes independently of the presence of
linker histones. (A) Agarose gel of nucleosomes reconstituted onto
methylated 5S-pmbs37 DNA without (H1) or with (+H1) histone
H1. Agarose gels were used to monitor the binding of H1 to
nucleosomes as a clear shift (N +H1) can only be observed in this
type of gels but not in native-PAGE [29,37]. (B) The appropriate
N + H1 complexes such as that shown in (A) were then used in further
MeCP2 gel shift using native-PAGE. Nucleosomes lacking (H1) or
containing (+H1) histone H1 (see also Fig. S3) upon addition of: 0
(lanes 1 and 6), 0.75 (lanes 2 and 7), 1.5 (lanes 3 and 8), 3.0 (lanes 4 and
9) and 6.0 (lanes 5 and 10) pmol of MeCP2. C, D and N are as in
previous ﬁgures.
Fig. 6. MeCP2 distribution in HeLa S3 cell chromatin. (A) (1) Sucrose grad
cells. The absorbance at 260 nm (A260) and the sucrose concentration of coll
the (a–d) shown in (1) Starting DNA from SI and SE samples are shown in c
DNA of the SI nucleosomes. (3) Western blot analysis of the MeCP2 presen
composition of the SI, SE and P fractions generated by micrococcal nuclease
CfoI-digested marker. (2) SDS–PAGE protein analysis of fractions SI, SE and
antibody. (4) AU–PAGE of SI, SE and P fractions. The vertical line on th
acetylated forms of H4.
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major diﬀerences were observed between MeCP2 binding to
nucleosomes reconstituted with either non-acetylated or acety-
lated core histone octamers (Fig. 4B).
Finally, our in vitro studies show that MeCP2 can bind to
the nucleosome in the presence of histone H1. To perform this,
nucleosomes were ﬁrst titrated (results not shown) with histone
H1 using agarose gel electrophoresis [29] to determine the
amount of histone H1 required to shift the nucleosome to a
nucleosome complex consisting of approximately 1 molecule
of H1 per nucleosome (Fig. 5A, lane +H1, N + H1). Beyond
this point, a complex with two molecules of H1 per nucleo-
some and higher aggregates were observed (results not shown)
[29]. Under these chosen experimental conditions, H1 asym-
metrically protects the DNA and overlaps with the binding site
of MeCP2 in the 5S-pmbs37 {Fig. S3 (see also [18])}. The
MeCP2 gel shifts using the N + H1 complexes are shown in
Fig. 5B and show an almost indistinguishable pattern. Due
to the large excess of non-radioactively labeled competitor
DNA used in the nucleosome reconstitution experiments (see
supplemental experimental procedures), it is almost impossible
to perform histone H1/MeCP2 competition experiments thatient fractionation of the nucleosome SI fraction obtained from HeLa
ected fractions are shown. (2) DNA composition of SI nucleosomes of
omparison. The two arrowheads point to the range (146–160 bp) of the
t in the sucrose gradient fractions. (B) (1) Native-PAGE of the DNA
digestion of native and butyrate-treated HeLa S3 nuclei. M: pBR322-
P. (3) Western blot analysis of the gel shown in (2) using an a-MeCP2
e left of B4 indicates the range of H4 isoforms with 0–4 denoting the
T. Ishibashi et al. / FEBS Letters 582 (2008) 1157–1162 1161allow us to monitor the displacement of one protein by the
other. Nevertheless, the shifted band in lane 9 of Fig. 5 and
the strong similarity of the MeCP2 shifts both in the absence
and in the presence of histone H1 suggest that histone H1 does
not prevent MeCP2 from binding. An N + H1 band is not ob-
served in lane 6 (Fig. 5B) due to the resolving limitations of na-
tive-PAGE. Otherwise, this complex is observed using agarose
gel electrophoresis (Fig. 5A).3.3. MeCP2 binds to the nucleosome proximal region of the
linker in vivo and is found predominantly associated with
histone H1-depleted nucleosomes in HeLa S3 cells
The relevance of the results described in the preceding sec-
tions ultimately depends on whether they are a true reﬂection
of what occurs in vivo. To this end, we used HeLa cells and a
simple micrococcal nuclease digestion that yields a histone H1-
depleted soluble fraction (SI) consisting of a mixture of 146–
160 bp nucleosomes and an H1-containing fraction (SE) con-
sisting of >168 bp nucleosomes and nucleosome oligomers
(Fig. 6A and B). Most of the MeCP2 unexpectedly eluted with
the SI fraction, and the result was very similar when the cells
were grown in the presence of the histone deacetylase inhibitor
sodium butyrate (Fig. 6B2–B3).
This suggests, in agreement with the in vitro data, that core
histone acetylation does not inﬂuence the way MeCP2 binds to
the nucleosome. Furthermore, sucrose gradient fractionation
of the SI nucleosomes (Fig. 6A1) showed that MeCP2 binding
to nucleosomes was enhanced when DNA lengths were within
a 10 bp range above 146 bp (Fig. 6A) in striking similarity to
what was observed in vitro in Fig. 3C.
The SI and SE fractions represent the less tightly packed
euchromatin and facultative heterochromatin. Under the
digestion conditions used, these fractions comprised: SI
(11%), SE (26%), P (63%) in the untreated HeLa S3 cells and
SI (15%), SE (13%), P (72%) in the butyrate-treated fraction.
The lower amount of MeCP2 present in the butyrate-treated
HeLa cells chromatin is also intriguing, but agrees well with
the selective loss of DNA methylation that has been observed
upon treatment of diﬀerent cells with histone deacetylase
inhibitors [30,31]. Preliminary data from our lab using HpaII
and MspI digestions of nucleosomal DNA from the SI fraction
indicates a 6.7% decrease in the extent of methylation in the
fraction obtained from sodium butyrate treated cells compared
to untreated cells (see Fig. S4 and the supplementary experi-
mental procedures). Work is currently in progress in our lab
to analyze these observations further.3.4. Conclusions
The results presented here collectively show that MeCP2
binds to the linker DNA very close to the DNA entry and exit
sites of the nucleosome, both in vitro and in vivo. In contrast to
linker histones [32], MeCP2 needs the DNA to be methylated.
In vivo, the MeCP2-containing HeLa cell nucleosomes are
readily digested, suggesting that most of these nucleosomes oc-
cur outside of the tightly folded constitutive heterochromatin
[33]. Intuitively, such CpG pmbs in the proximity of a nucle-
ase-accessible nucleosome are more likely to occur in CpG rich
regions in facultative heterochromatin where MeCP2 (unlike
linker histones) could provide a distinctive binding site for het-
erochromatin protein 1 (HP1) [34] or other chromatin trans-
acting factors. The in vivo observations described in this paperare in excellent agreement with the recently published large-
scale mapping of neuronal MeCP2 binding sites showing that
63% of MeCP2 bound promoters are in actively expressed
genes [35].
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